Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...

By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, ...

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...

Fabian Gerlinghaus, Alexander Seyf, and Knut Steffensen go behind the headlines and dive into the advanced therapy ecosystem.